Home Data Calendar Blog

XNCR

Tables

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Common Stock Value 0.610.610.610.600.600.600.600.600.590.580.580.580.580.570.570.570.570.570.560.560.560.560.470.470.470.47
Earnings Per Share Basic -0.31-0.40-0.37-1.02-0.21-0.55-0.570.401.26-0.690.90-0.04-0.24-0.22-0.61-0.14-0.47-0.18-0.281.42-0.320.06-0.25-0.33-0.15-0.31
Earnings Per Share Diluted -0.31-0.40-0.37-1.02-0.21-0.55-0.570.391.21-0.690.87-0.04-0.24-0.22-0.61-0.14-0.47-0.18-0.281.38-0.320.05-0.25-0.33-0.15-0.31

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Revenue From Contract With Customer Excluding Assessed Tax 44.6959.1645.5218.9621.6127.3030.1885.50154.0119.6867.4533.9741.8535.3713.0932.383.5221.7619.48111.9411.5629.0430.150.0012.503.50
Revenues 44.6959.1645.5218.9621.6127.3030.1885.50154.0119.6867.4533.9741.8535.3713.0932.383.5221.7619.48111.9411.5629.0430.150.0012.503.50
Operating Expenses 79.7077.4371.5278.3364.2065.6558.1759.0362.3660.9858.3649.6455.5552.0950.6941.1634.0936.0439.0633.7032.6528.3924.8223.5821.0119.86
Research And Development Expense 64.2264.9460.0664.3851.4553.2747.0847.7650.9950.6149.5041.4147.9544.4543.4633.9427.3429.7733.3028.1827.1320.9520.4019.4116.9215.05
General And Administrative Expense 15.4812.4911.4613.9512.7512.3711.0911.2711.3810.378.868.237.607.647.237.226.756.275.765.515.527.434.434.174.094.81
Operating Income Loss -35.01-18.27-26.00-59.37-42.59-38.35-28.0026.4791.65-41.309.09-15.67-13.70-16.72-37.60-8.78-30.57-14.28-19.5778.24-21.080.65-13.88-16.49-7.67-15.52
Interest Income Expense Net 6.955.023.762.892.071.380.720.650.290.200.150.210.711.422.093.043.423.703.622.892.812.641.051.04NANA
Interest Paid Net 0.000.010.010.010.000.000.010.000.000.000.010.000.000.000.010.010.000.000.000.000.010.000.010.000.000.00
Profit Loss -19.26-24.27-21.95-60.76-12.04-32.76-33.9723.5973.06-40.1952.25-2.49-13.69-12.55-35.02-8.07-26.91-10.22-16.0380.05-18.203.15-11.84-15.56-6.04-15.47
Net Income Loss -19.10-24.27-21.95-60.76-12.04-32.76-33.9823.5973.06-40.1952.25-2.49-13.69-12.55-35.02-8.07-26.91-10.22-16.0380.05-18.203.15-11.84-15.56-6.88-14.63
Comprehensive Income Net Of Tax -17.10-23.12-20.19-57.44-9.12-33.69-35.8017.9871.63-40.2552.14-2.46-14.18-13.47-34.59-8.18-27.19-10.42-14.7581.36-16.832.82-12.55-15.42-6.93-14.39
Net Income Loss Available To Common Stockholders Basic -19.10-24.27-21.95-60.76-12.04-32.76-33.9823.5973.06-40.1952.25-2.49-13.69-12.55-35.02-8.07-26.91-10.22-16.0380.05-18.203.15-3.07-22.65-7.72-15.47

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Assets 952.69778.43778.12803.41846.27835.27851.33857.92838.21697.26695.60692.74703.24646.35644.72666.96670.25686.24684.75697.00576.73585.59390.10398.25416.16418.30
Liabilities 283.56109.4299.25119.83118.77112.57108.9894.90104.7178.4048.66109.12130.8077.8774.0873.9677.0576.0176.6687.4455.0553.31108.06107.72114.80114.56
Liabilities And Stockholders Equity 952.69778.43778.12803.41846.27835.27851.33857.92838.21697.26695.60692.74703.24646.35644.72666.96670.25686.24684.75697.00576.73585.59390.10398.25416.16418.30
Stockholders Equity 668.80669.01678.88683.58727.50722.70742.34763.02733.50618.86646.94583.61572.44568.48570.64593.00593.20610.24608.09609.57521.68532.27282.05290.54301.37303.75

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Assets Current 623.16571.18593.56629.98675.34668.00585.94505.97424.37329.63480.97591.17637.67570.88603.39588.11558.40573.76527.01488.67315.73286.92230.88217.81210.98166.09
Cash And Cash Equivalents At Carrying Value 53.7952.7334.7172.3953.9452.6549.4178.27143.4841.20115.84176.97163.5458.09109.5373.8150.3151.1932.5621.8626.2535.0016.5313.6311.2213.56
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 54.1753.1134.7172.3953.9452.6549.4178.27143.4841.20115.84176.97163.5458.09109.5373.8150.3151.1932.5621.8626.2535.0016.5313.6311.22NA
Accounts Receivable Net Current 11.2955.0020.0219.8629.0044.8854.2888.2066.3820.5514.8212.5311.449.538.936.8321.574.3510.13137.6810.192.461.140.8314.886.94
Prepaid Expense And Other Assets Current 18.1421.6422.1722.0923.2822.8919.7323.0123.8820.8815.5914.1610.7310.197.406.486.557.5311.319.4310.3812.105.617.037.624.37
Equity Securities Fv Ni 42.2128.9739.9939.7142.4332.1826.8933.4336.8647.5845.236.145.305.382.612.25NANANANANANANANANANA
Available For Sale Securities Debt Securities 643.24433.25NA475.92530.51557.12576.04517.09454.23476.17442.60393.96435.19519.46475.26536.07551.00569.29593.58490.97504.22512.83NA359.37367.51379.09

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Property Plant And Equipment Gross 102.35NANANA87.47NANANA51.07NANANA38.71NANANA28.41NANANA21.24NA15.04NANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 36.23NANANA28.29NANANA22.83NANANA17.03NANANA12.61NANANA9.43NA7.95NANANA
Property Plant And Equipment Net 66.1268.0368.0066.6959.1851.0438.8528.4128.2424.1823.1322.3021.6819.7716.2416.8015.8013.8712.1311.4611.819.697.096.083.863.36
Intangible Assets Net Excluding Goodwill 18.6618.7418.7118.2418.5018.0917.9416.7116.4916.6816.3815.5515.9815.3215.1614.6414.4214.0313.5212.7411.9711.6811.1511.0410.8710.89
Finite Lived Intangible Assets Net 8.54NANANA8.77NANANA7.27NANANA7.15NANANANANANANANANANANANANA
Other Assets Noncurrent 0.650.660.600.600.610.610.610.610.6533.454.3510.420.218.618.799.190.3110.1910.7311.270.310.310.270.270.210.10
Equity Securities Fv Ni 42.2128.9739.9939.7142.4332.1826.8933.4336.8647.5845.236.145.305.382.612.25NANANANANANANANANANA
Available For Sale Debt Securities Amortized Cost Basis 641.93433.94NA479.54537.46566.98584.97524.20455.73476.23442.60393.85435.10518.88473.77535.01549.83567.84591.94490.62505.18515.16NA360.46368.74380.28

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Liabilities Current 84.7153.0444.6365.0663.8490.0375.0460.9470.7444.3245.9699.93121.0670.4966.4565.9266.5664.3163.7173.3253.8552.03101.34100.33107.43106.88
Debt Current 6.33NANANANANANANANANANANANANANANANANANANANANANANANANA
Accounts Payable Current 13.9114.9714.1015.3410.0914.6215.7511.9014.009.137.117.668.9513.1110.5110.3110.198.308.995.493.805.986.876.607.384.28
Accrued Income Taxes Current 5.78NANANANANANANANANANANANANANANANANANANANANANANANANA
Accrued Liabilities Current 23.5624.4718.4415.1418.7319.2916.3512.6119.4422.1117.3312.5117.6011.389.167.298.997.836.235.719.665.675.484.643.986.50

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Long Term Debt Noncurrent 14.64NANANANANANANANANANANANANANANANANANANANANANANANANA
Minority Interest 0.34NANANANANANANANANANANANANANANANANANANANANANANANANA
Operating Lease Liability Noncurrent 59.0256.3854.6254.7754.9322.5433.9433.9633.9734.092.709.199.747.387.638.048.569.089.6510.22NANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Stockholders Equity 668.80669.01678.88683.58727.50722.70742.34763.02733.50618.86646.94583.61572.44568.48570.64593.00593.20610.24608.09609.57521.68532.27282.05290.54301.37303.75
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 669.13NANANA727.50NANANA733.50NANANA572.44NANANANANANANANANANANANANA
Common Stock Value 0.610.610.610.600.600.600.600.600.590.580.580.580.580.570.570.570.570.570.560.560.560.560.470.470.470.47
Additional Paid In Capital 1131.271114.381101.131085.651072.131058.221044.171029.061017.52974.51962.34951.15937.52919.39908.08895.86887.87877.72865.16851.89845.37839.13570.67566.61562.02557.47
Retained Earnings Accumulated Deficit -464.37-445.27-421.00-399.05-338.29-326.24-293.49-259.51-283.10-356.17-315.97-368.22-365.74-352.04-339.49-304.48-296.40-269.49-259.27-243.23-323.28-305.08-287.29-275.44-259.88-253.00
Accumulated Other Comprehensive Income Loss Net Of Tax 1.29-0.71-1.86-3.62-6.95-9.88-8.94-7.12-1.51-0.07-0.010.100.070.571.481.061.161.441.630.34-0.97-2.34-1.81-1.10-1.24-1.20
Minority Interest 0.34NANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Operating Activities 181.21-27.28-38.20-30.61-24.43-1.1744.275.8261.79-39.02-9.65-29.9717.08-3.87-27.689.46-19.58-6.48109.16-18.73-16.78-10.31-6.67-3.51-12.96-10.55
Net Cash Provided By Used In Investing Activities -203.1345.33-1.4148.1424.553.12-75.64-71.767.86-38.85-53.3138.0578.78-50.5659.4112.5615.7322.06-102.4313.676.875.868.944.939.538.55
Net Cash Provided By Used In Financing Activities 22.980.361.920.921.171.292.510.7332.633.231.845.349.592.994.001.472.973.053.970.671.174.150.620.991.101.03

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Operating Activities 181.21-27.28-38.20-30.61-24.43-1.1744.275.8261.79-39.02-9.65-29.9717.08-3.87-27.689.46-19.58-6.48109.16-18.73-16.78-10.31-6.67-3.51-12.96-10.55
Net Income Loss -19.10-24.27-21.95-60.76-12.04-32.76-33.9823.5973.06-40.1952.25-2.49-13.69-12.55-35.02-8.07-26.91-10.22-16.0380.05-18.203.15-11.84-15.56-6.88-14.63
Profit Loss -19.26-24.27-21.95-60.76-12.04-32.76-33.9723.5973.06-40.1952.25-2.49-13.69-12.55-35.02-8.07-26.91-10.22-16.0380.05-18.203.15-11.84-15.56-6.04-15.47
Depreciation Depletion And Amortization 3.233.142.882.252.162.242.222.182.111.991.751.641.531.451.441.371.231.071.011.000.880.820.610.560.450.41
Increase Decrease In Accounts Payable -1.050.87-1.255.25-4.53-1.133.84-2.104.872.02-0.55-1.29-4.162.600.200.121.88-0.693.511.69-2.191.070.27-0.783.100.40
Share Based Compensation 14.7012.9013.5612.6012.7412.7612.6010.8010.398.949.358.298.568.328.236.517.189.519.305.865.086.123.443.603.453.16

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Investing Activities -203.1345.33-1.4148.1424.553.12-75.64-71.767.86-38.85-53.3138.0578.78-50.5659.4112.5615.7322.06-102.4313.676.875.868.944.939.538.55
Payments To Acquire Property Plant And Equipment 0.982.833.8510.789.9714.0912.352.096.322.752.281.953.154.700.622.072.912.581.450.412.791.011.482.580.760.49

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Financing Activities 22.980.361.920.921.171.292.510.7332.633.231.845.349.592.994.001.472.973.053.970.671.174.150.620.991.101.03

    2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Revenues 44.6959.1645.5218.9621.6127.3030.1885.50154.0119.6867.4533.9741.8535.3713.0932.383.5221.7619.48111.9411.5629.0430.150.0012.503.50
Alexion Pharmaceuticals Inc 5.2031.8011.2010.509.207.306.706.105.805.805.205.3014.704.303.803.302.505.405.10NA11.009.00NANANANA
Gilead 0.006.00NANANANANANANANANANA0.000.007.506.00NANANANANANANANANANA
Janssen 36.7013.7022.205.204.900.100.201.8076.806.3016.2014.60NANANANANANANANANANANANANANA
Morpho Sys 2.102.702.001.802.202.101.202.302.001.301.2013.901.3025.200.0012.50NANANANANANANANANANA
Zenas Bio Pharma Limited 0.000.0010.00NANANANANANANANANANANANANANANANANANANANANANANA
Royalty 8.0014.5013.3013.8016.2027.2030.0078.7052.9013.407.306.706.104.503.803.302.501.401.10NANANANANANANA
Milestone 27.5046.0010.005.000.500.000.005.007.000.001.5012.5012.4025.000.3012.50-0.1019.304.00NA11.509.00NANANANA
Revenue From Contract With Customer Excluding Assessed Tax 44.6959.1645.5218.9621.6127.3030.1885.50154.0119.6867.4533.9741.8535.3713.0932.383.5221.7619.48111.9411.5629.0430.150.0012.503.50
Alexion Pharmaceuticals Inc 5.2031.8011.2010.509.207.306.706.105.805.805.205.3014.704.303.803.302.505.405.10NA11.009.00NANANANA
Gilead 0.006.00NANANANANANANANANANA0.000.007.506.00NANANANANANANANANANA
Janssen 36.7013.7022.205.204.900.100.201.8076.806.3016.2014.60NANANANANANANANANANANANANANA
Morpho Sys 2.102.702.001.802.202.101.202.302.001.301.2013.901.3025.200.0012.50NANANANANANANANANANA
Zenas Bio Pharma Limited 0.000.0010.00NANANANANANANANANANANANANANANANANANANANANANANA
Royalty 8.0014.5013.3013.8016.2027.2030.0078.7052.9013.407.306.706.104.503.803.302.501.401.10NANANANANANANA
Milestone 27.5046.0010.005.000.500.000.005.007.000.001.5012.5012.4025.000.3012.50-0.1019.304.00NA11.509.00NANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Other Nonoperating Income Expense
Balance Sheet
Long Term Debt Noncurrent
Assets
Intangible Assets Net Excluding Goodwill
Current Assets
Accounts Receivable Net Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Operating Lease Liability
Current Liabilities
Operating Lease Liability Current
Noncurrent Liabilities
Minority Interest
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Other Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Next Twelve Months

Line plots across dimensions of each concept